4142.TW
Price:
$17.25
Market Cap:
$7.27B
Adimmune Corporation, a Taiwanese pharmaceutical company, specializes in the production and distribution of human vaccines. Its comprehensive product portfolio includes a range of critical immunizations. Key offerings feature the quadrivalent influenza vaccine, AdimFlu-S, alongside trivalent influenza vaccines and the Influenza A (H1N1) Virus Monovalent Vaccine. The company also provides tetanus toxoid products, vital for post-injury tetanus prevention, and Japanese encephalitis vaccines. Furthermore, Adimmune supplies purified Tuberculin and extends its expertise through contract manufacturing services. Established in 1965, the company initially operated under the name Kuo Kwang Serum and V...[Read more]
Industry
Biotechnology
IPO Date
2012-05-03
Stock Exchange
TAI
Ticker
4142.TW
According to Adimmune Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -35.20. This represents a change of 7.21% compared to the average of -32.83 of the last 4 quarters.
The mean historical PE Ratio of Adimmune Corporation over the last ten years is 37.24. The current -35.20 PE Ratio has changed -9553.41% with respect to the historical average. Over the past ten years (40 quarters), 4142.TW's PE Ratio was at its highest in in the June 2022 quarter at 88.86. The PE Ratio was at its lowest in in the September 2018 quarter at -181.56.
Average
37.24
Median
-8.12
Minimum
-34.66
Maximum
446.50
Discovering the peaks and valleys of Adimmune Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.31%
Maximum Annual PE Ratio = 446.50
Minimum Annual Increase = -156.35%
Minimum Annual PE Ratio = -34.66
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -33.25 | -4.07% |
| 2024 | -34.66 | 58.90% |
| 2023 | -21.81 | -141.66% |
| 2022 | 52.35 | -88.27% |
| 2021 | 446.50 | 2.31% |
| 2020 | 18.51 | -156.35% |
| 2019 | -32.86 | 353.39% |
| 2018 | -7.25 | 16.88% |
| 2017 | -6.20 | -31.12% |
| 2016 | -9.00 | 17.04% |
The current PE Ratio of Adimmune Corporation (4142.TW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-29.90
5-year avg
81.83
10-year avg
37.24
Adimmune Corporation’s PE Ratio is greater than CHO Pharma, Inc. (-85.56), less than TaiGen Biopharmaceuticals Holdings Limited (113.39), less than Mycenax Biotech Inc. (-11.75), less than Pharmosa Biopharm Inc. (-10.75), less than Acepodia, Inc. (-8.88), less than AP Biosciences Inc (-19.79), less than OBI Pharma, Inc. (-0.85), greater than BioGend Therapeutics Co., Ltd. (-47.41), less than Sinphar Pharmaceutical Co. Ltd. (18.11), less than PharmaEngine, Inc. (21.39),
| Company | PE Ratio | Market cap |
|---|---|---|
| -85.56 | $24.72B | |
| 113.39 | $6.45B | |
| -11.75 | $5.13B | |
| -10.75 | $4.15B | |
| -8.88 | $6.70B | |
| -19.79 | $10.04B | |
| -0.85 | $3.44B | |
| -47.41 | $3.38B | |
| 18.11 | $6.39B | |
| 21.39 | $9.04B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adimmune Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Adimmune Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Adimmune Corporation's PE Ratio?
How is the PE Ratio calculated for Adimmune Corporation (4142.TW)?
What is the highest PE Ratio for Adimmune Corporation (4142.TW)?
What is the 3-year average PE Ratio for Adimmune Corporation (4142.TW)?
What is the 5-year average PE Ratio for Adimmune Corporation (4142.TW)?
How does the current PE Ratio for Adimmune Corporation (4142.TW) compare to its historical average?